US Medical Management changes name to HarmonyCares
Troy-based US Medical Management LLC is changing its name after an acquisition by a Nashville private equity firm.
Rubicon Partners led the acquisition, along with other investment firms, to buy a majority stake in the management services organization in December 2021 from public company Centene Corp. based in Saint Louis. Terms of the deal were not disclosed, but Centene acquired a 68% stake. majority stake in USMM in 2013. It is unclear whether Centene held this stake or changed it before selling it to Rubicon.
Beginning Thursday, USMM will be called HarmonyCares.
The newly named entity employs approximately 500 people and is the parent company of Visiting Physicians Association, Pinnacle Senior Care and Grace Hospice, among other home-based primary care companies. VPA is an organization of home-based primary care physicians that operates in 11 states.
“The name change from USMM to HarmonyCares reinforces that we are an organization with different divisions working in perfect harmony: providing personalized care to patients wherever they are in their healthcare journey,” said organization in a press release. “HarmonyCares is unique in healthcare because we provide everything under one roof, in one company: home medical care, nursing support, therapy, palliative care and home labs. – and you never have to leave your home.”
Rubicon Partners and HarmonyCares management unveiled the new name at an event in Troy on Thursday morning.
However, the company has shrunk in recent years and faced challenges with federal oversight.
In 2012, the company employed nearly 2,000 people nationwide with revenue of $162 million. It is not known what his current income is.
In October 2021, VPA and USMM agreed to pay $8.5 million to settle federal allegations that the organizations sought reimbursement from Medicare for unnecessary lab tests.
The U.S. Department of Justice said VPA and USMM received millions of dollars from Medicare between Jan. 1, 2010, and Dec. 31, 2015, for diagnostic lab tests that the DOJ deemed “unreasonable and necessary for diagnosis.” or the treatment of a disease”. or injury.”
The DOJ participated in five lawsuits against VPA and USMM, all of which were part of the settlement.
A lawsuit, filed in US District Court in Detroit in 2018, alleged VPA protocols forced doctors and nurses to order unnecessary tests for patients.
“Laboratories and testing…were based on VPA’s assumptions that ‘most patients’ had ‘multiple comorbid chronic conditions treated with multiple medications, atypical and/or non-specific clinical presentations, and functional disorders involving physical, behavioral, cognitive, and/or psychiatric manifestations,” the lawsuit alleged. “These assumptions…, however, are not based on the specific condition of the patient. Nor could they be because VPA had no information about the specific patient…”
Assistant United States Attorney John Spaccarotella of the United States Attorney’s Office for the Eastern District of Michigan was in charge of the case against VPA and USMM.